GLOW

GLOW

70mg / Single Vial
$170.00
Sale price  $170.00 Regular price 
Skip to product information
GLOW

GLOW

$170.00
Sale price  $170.00 Regular price 
Size70mg
Quantity

Research Use Only

All products are intended solely for laboratory research and are not for human or animal consumption. By purchasing, the buyer agrees to use these products in compliance with all applicable laws.

GLOW Blend Overview

The GLOW Blend combines three synthetic peptides studied for their roles in molecular signaling and pathway dynamics: GHK-Cu, BPC-157, and TB-500. Together, these peptides are investigated for their influence on angiogenesis, extracellular matrix remodeling, and systemic signaling pathways. In laboratory and preclinical models, the combination provides a platform for exploring synergistic effects in matrix integrity, vascular formation, and molecular resilience.

Pickart L. et al. (2015)

History

The concept of the GLOW Blend arises from decades of research into individual signaling peptides. GHK-Cu was first identified in biological plasma samples in the 1970s and later studied for gene regulation and matrix remodeling activity. BPC-157 was synthesized in the 1990s as a gastric protein fragment analog and has since been researched for angiogenic and structural processes. TB-500, derived from thymosin beta-4, traces its research lineage to thymus peptide studies in the 1960s and is recognized for its effects on molecular migration and angiogenesis. Combined, these peptides represent a convergence of experimental research lines.

Sikiric P. et al. (1993)

GHK-Cu Structure



CAS #: 49557-75-7

Molecular Formula: C₁₄H₂₄CuN₆O₄

Molecular Weight: 340.9 g/mol

PubChem ID: 5311476

BPC-157 Structure




Molecular Formula: C₁₄H₂₄CuN₆O₄
Molecular Weight: 340.9 g/mol
PubChem ID: 5311476

TB-500 Structure




Formula: C₂₁₂H₃₅₀N₅₆O₇₈S
Molecular Weight: 4963.5 g/mol
PubChem ID: 16132321

Research Findings

The GLOW Blend, which combines GHK-Cu, BPC-157, and TB-500, has been studied across structural, epithelial, vascular, and systemic models. Research highlights its activity in collagen organization, molecular migration, angiogenesis, and molecular signaling. Together, these peptides complement one another by engaging pathways linked to matrix remodeling, pathway dynamics, and resilience in preclinical settings.

Key Areas of Research:

  • Structural: Collagen, matrix, tendon/ligament

  • Epithelial: Migration, matrix signaling, follicle dynamics

  • Vascular: Angiogenesis, nitric oxide, formation

  • Systemic: Signaling, viability, pathway dynamics

Together, these findings suggest broad experimental potential for the GLOW Blend across multiple biological pathways. By combining structural support, vascular formation, and epithelial remodeling with systemic signaling, the GLOW Blend provides a versatile platform for research into molecular dynamics, matrix characterization, and overall biological resilience in laboratory settings.

Pickart L. et al., 2015

You may also like